Articles On Sigma Healthcare (ASX:SIG)

In 2026, I'm focused on owning businesses with clear competitive advantages, sensible balance sheets, and management teams that have proven they can execute. They are ASX stocks I would be comfortable holding through market volatility,...

As 2026 gets underway, I'm looking for ASX stocks that I believe can continue to grow, adapt, and compound value over time. With that in mind, these are five stocks I'm particularly eager to buy for my portfolio in 2026. DroneShield...

At the beginning of a new year, I like to narrow my focus rather than expand it. Instead of looking at dozens of ASX stocks, I concentrate on a small group of businesses I would genuinely be happy to own for the long term. These are com...

As we look ahead to 2026, I'm less focused on predicting short-term market moves and more interested in owning businesses that can continue to compound value over time. The ASX 200 is home to many of Australia's highest-quality companies...

Owning Sigma Healthcare Ltd (ASX: SIG) shares could be a pleasing choice for long-term dividend income. It may not have a reputation for being an ASX dividend share year, but if it's able to deliver year after year growth, then it could...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin The Nasdaq rallied as Tesla shares hit a new all time high while oil prices continue...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Technology stocks led by Oracle and Broadcom continued to weigh on the Nasdaq overni...

Highlights Broad market pressure weighs on Australian equities Commodity weakness shapes mining sentiment Defensive and selective sectors show resilience Australian equities opened the week under pressure as commodity...

In a pre-Christmas rush, biotechs report a flurry of clinical activity Radiopharm shares surge up to 22% on strong brain-imaging results Morgans says Sigma Health and EBOS Group shares are just the prescription for the Christmas hamper  ...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Led by a sell off in Broadcom and Oracle, the Nasdaq led US markets lower on Friday...

The team at Macquarie just released its latest High Frequency Consumer Data report and consumer stock picks.  This included stock picks from both consumer discretionary and staples sectors.  Its High Frequency Consumer Data series pro...

It was a tough Tuesday for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares today. After a bouncy day, the ASX 200 ended up closing 0.45% lower, probably unassisted by the Reserve Bank of Australia'...

The Sigma Healthcare Ltd (ASX: SIG) share is slowly slipping toward this year's record low of $2.74. Monday it lost another 2% to close at $2.79. In 2025, the $33 billion dollar pharmacy group has lost 5.2% in value and in the past 6 mon...

The L1 Long Short Fund Ltd (ASX: LSF) is one of the most successful ASX stocks on the Australian share market. Since duplicating its managed fund into a listed investment company (LIC) back in 2018, this LIC's portfolio has generated an ave...

Highlights Clear snapshot of major uptrends and downtrends across sectors Quick context on why scan lists matter for market monitoring Thematic takeaways across resources, property, healthcare and tech Today’s trend sc...

Good Afternoon and welcome to the start of Week 49 I’m Jon Davidson. I’d say here’s to a happy December, but you might be among shareholders caught up in today’s ASX announcements outage, the latest bungle to come from the bourse operator,...

Two leading investment experts say that now is the time to sell these three S&P/ASX 200 Index (ASX: XJO) stocks. One of the companies is a fast food operator, the second is an Aussie rare earths miner, and the third is an Australian ret...

Owning Sigma Healthcare Ltd (ASX: SIG) shares means gaining exposure to several healthcare businesses, including Chemist Warehouse. After dropping 7% since the November peak, I think it's worth asking whether the business is a buy-the-dip o...

The CSL Ltd (ASX: CSL) share price decline of 35% this year (at the time of writing) is one of the biggest among ASX blue-chip shares in 2025. While the company has decades of delivering growth under its belt, the market now seems mo...

One of the many positives of ASX ETFs is the ability to gain exposure to niche themes or sectors.  A trend that is becoming increasingly prevalent is the focus on ESG investing. ESG investing is based on environmental, social, and gov...

When markets get choppy, many investors sit on the sidelines waiting for conditions to get better. But long-term wealth is built by doing the opposite, buying high-quality stocks when uncertainty drags their share prices lower. Right now, t...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) fought hard and recorded a small gain. The benchmark index rose 0.15% to 8,537 points. Will the market be able to build on this on Wednesday? Here are five things to watch: ASX 200 expected...

Shares in the S&P/ASX 200 Index (ASX: XJO) biotech stock CSL Ltd (ASX: CSL) closed yesterday trading for $182.14. CSL shares remain down a sharp 35.32% in 2025. Taking a tiny bit of the sting out of those losses, the ASX 200 stock also...

Felix Gold Ltd (ASX: FXG) has become one of the ASX's standout performers over the past twelve months. Shares in this mineral explorer have ballooned by nearly 500% in just one year, climbing to $0.41 per share at the time of writing....

If you have space in your portfolio for some new additions, it could be worth hearing what analysts are saying about the ASX shares in this article, courtesy of The Bull. Let's see if they are buys, holds, or sells right now: CSL Ltd (ASX:...

With 2026 fast approaching, we look at three S&P/ASX 200 Index (ASX: XJO) titans leading analysts expect to outperform in the months ahead. One of the promising companies operates in the global defence space, while the other two are in...

CSL Ltd (ASX: CSL) shares are marching higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) biotech stock closed yesterday trading for $180.08. In morning trade on Wednesday, shares are changing hands for $181.73 apiece, up 0.9%%....

Sonic Healthcare Ltd (ASX: SHL) has hit its lowest share price in years. On Tuesday the prominent ASX 200 share closed lower on $20.89, which brings the loss this year to 23%. Sonic Healthcare is a global diagnostics and pathology powerh...

CSL Ltd (ASX: CSL) shares have been in the spotlight in recent weeks. Following the release of a disappointing trading update, the biotechnology giant's shares have tumbled into the red again. Is this a buying opportunity? Let's see what an...

ASX 200 healthcare shares are among just two market sectors in the green today, with the other nine all in the red. The S&P/ASX 200 Health Care Index (ASX: XHJ) is up 0.085% compared to a 1% decline for the S&P/ASX 200 Index (A...

Time and again we've seen how leading S&P/ASX 200 Index (ASX: XJO) blue-chip shares are capable of delivering strong profits and returns for shareholders. There's usually a reason why that business has risen to the top of the pile an...

Pfizer has won a spirited bidding war for the GLP-1 drug developer Metsera Pharmx launches its eBay for chemists Gough-era biotech stocks maintain the rage     A fierce US$10 billion bidding war for the Nasdaq-listed anti-obesity drug mak...

It’s no easy gig analysing share prices and company performance but somebody’s got to do it. Every week two experts from our Share Tips columnist pool give us their recommendations.    Andrew Eddy – Morgans Financial BUY EBR Systems (ASX:E...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Updates on Model Portfolios, Best Buys, Top Picks, Sector favourites and Conviction...

ELM Responsible Investments’ quest is to find the most ‘sustainable’ companies – but not by ticking ESG boxes The fund is keen on Australian healthcare stocks and AI driven data centre plays As with most forms of stock picking, returns are...

ASX 200 healthcare shares are outperforming on Friday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) up 0.4% compared to the S&P/ASX 200 Index (ASX: XJO) up 0.25%. In new notes, top broker Morgans has revealed its verdict o...

Highlights Key movers identified across ASX-listed sectors Mining and energy players gained notable momentum Healthcare and consumer stocks faced market pressure ASX 200 weekly review spotlighted contrasting performanc...

The Pro Medicus Ltd (ASX: PME) share price closed at $263.34 on Thursday. The medical imaging software and services company has established itself as a sharemarket darling in recent years. Ongoing contract wins around the world and...

Shares in Sigma Healthcare (ASX:SIG) have surged over the past year. The recent merger with Chemist Warehouse has improved SIG’s fundamentals on several fronts. In particular, financial results have demonstrated store network growth, improv...

S&P/ASX 200 Index (ASX: XJO) shares have delivered a very pleasing return for investors. In 2025 to date, the ASX 200 has risen by 10%, plus dividends. That's an above-average return for the Australian share market and the year hasn't e...

It’s no easy gig analysing share prices and company performance but somebody’s got to do it. Every week two experts from our Share Tips columnist pool give us their recommendations.                      Chris Watt – Bell Potter Securities...

One of the most popular options for investors in the gold industry is Northern Star Resources Ltd (ASX: NST). This isn't surprising given the quality of its operations and their low costs. But is it a good option for investors wanting expos...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Australia's AGM season is generating some upbeat stories, with rare earths taking US...

For many Australians, the idea of building a $250,000 share portfolio can feel out of reach. But it is far more achievable than most people think, and it doesn't require a huge starting balance, fancy trading strategies, or perfect timing....

On Thursday, the S&P/ASX 200 Index (ASX: XJO) fought hard and managed to record the smallest of gains. The benchmark index rose slightly to 9,032.8 points. Will the market be able to build on this on Friday and end the week on a high?...

Looking for a high yielding S&P/ASX 200 Index (ASX: XJO) dividend stock that's also well-placed to deliver market beating share price gains? Then you might want to have a look into international toll road operator and developer Atlas A...

Sigma Healthcare Ltd (ASX: SIG) shares are trading in the green on Thursday afternoon. At the time of writing, the ASX-listed pharmaceutical company's share price is 1.47% higher at $3.10 each. It's been a great year for Sigma Healthcare...

If you're in your 40s with around $100,000 in superannuation, you're almost exactly average. According to the Australian Retirement Trust, men aged 35–44 have an average balance of about $107,700, while women of the same age average $7...

Highlights Energy sector leads gains despite market softness. Key ASX 200 companies post mixed quarterly updates. Gold and mining stocks steady as global sentiment fluctuates. The ASX 200 saw a mild decline as energy stocks gained...